IMMUNOVANT, INC. Earnings Per Share (Basic)
IMMUNOVANT, INC. (IMVT) reported Earnings Per Share (Basic) of -$0.75 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- IMMUNOVANT, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.75.
- IMMUNOVANT, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.73.
- IMMUNOVANT, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.61.
- IMMUNOVANT, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.73.
- IMMUNOVANT, INC. earnings per share, basic for fiscal 2026 was -$2.77.
- IMMUNOVANT, INC. earnings per share, basic for fiscal 2025 was -$2.73.
- IMMUNOVANT, INC. earnings per share, basic for fiscal 2024 was -$1.88.
- IMMUNOVANT, INC. earnings per share, basic for fiscal 2023 was -$1.71.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.75 10-Q · filed 2026-08-06 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.09 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.82 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$2.07 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$2.77 10-K · filed 2026-05-20 |
| 2025-12-31 | -$0.61 10-Q · filed 2026-02-06 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-02-06 | -$2.04 10-Q · filed 2026-02-06 | -$2.68 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-09-30 | -$0.73 10-Q · filed 2025-11-10 | -$1.43 10-Q · filed 2025-11-10 | -$2.08 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.82 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.71 10-Q · filed 2026-08-06 | -$1.35 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.09 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.84 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$2.13 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$2.73 10-K · filed 2026-05-20 |
| 2024-12-31 | -$0.76 10-Q · filed 2026-02-06 | -$1.50 derived: net income ÷ weighted average shares · filed 2026-02-06 | -$2.10 10-Q · filed 2026-02-06 | -$2.62 derived: net income ÷ weighted average shares · filed 2026-07-22 |
| 2024-09-30 | -$0.74 10-Q · filed 2025-11-10 | -$1.34 10-Q · filed 2025-11-10 | -$1.86 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$2.22 derived: net income ÷ weighted average shares · filed 2026-07-22 |
| 2024-06-30 | -$0.60 10-Q · filed 2025-08-11 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-07-22 |
| 2024-03-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.88 10-K · filed 2026-05-20 |
| 2023-12-31 | -$0.36 10-Q · filed 2025-02-06 | -$0.80 derived: net income ÷ weighted average shares · filed 2025-02-06 | -$1.36 10-Q · filed 2025-02-06 | -$1.82 derived: net income ÷ weighted average shares · filed 2026-07-22 |
| 2023-09-30 | -$0.45 10-Q · filed 2024-11-07 | -$1.01 10-Q · filed 2024-11-07 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.96 derived: net income ÷ weighted average shares · filed 2026-07-22 |
| 2023-06-30 | -$0.57 10-Q · filed 2024-08-06 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-07-22 |
| 2023-03-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.36 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.71 10-K · filed 2025-05-29 |
| 2022-12-31 | -$0.49 10-Q · filed 2024-02-12 | -$0.91 derived: net income ÷ weighted average shares · filed 2024-02-12 | -$1.26 10-Q · filed 2024-02-12 | -$1.66 derived: net income ÷ weighted average shares · filed 2026-07-22 |
| 2022-09-30 | -$0.41 10-Q · filed 2023-11-09 | -$0.76 10-Q · filed 2023-11-09 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.52 derived: net income ÷ weighted average shares · filed 2026-07-22 |
| 2022-06-30 | -$0.35 10-Q · filed 2023-08-10 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.46 derived: net income ÷ weighted average shares · filed 2026-07-22 |
| 2022-03-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-07-22 | -$1.43 10-K · filed 2023-05-22 |
| 2021-12-31 | -$0.36 10-Q · filed 2023-02-03 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-02-03 | -$1.02 10-Q · filed 2023-02-03 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-02-03 |
| 2021-09-30 | -$0.35 10-Q · filed 2022-11-04 | -$0.66 10-Q · filed 2022-11-04 | -$0.95 derived: net income ÷ weighted average shares · filed 2023-02-03 | -$1.27 derived: net income ÷ weighted average shares · filed 2023-02-03 |
| 2021-06-30 | -$0.31 10-Q · filed 2022-08-05 | -$0.60 derived: net income ÷ weighted average shares · filed 2023-02-03 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-02-03 | -$1.18 derived: net income ÷ weighted average shares · filed 2023-02-03 |
| 2021-03-31 | -$0.29 derived: net income ÷ weighted average shares · filed 2022-06-08 | -$0.61 derived: net income ÷ weighted average shares · filed 2022-06-08 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-06-08 | -$1.22 10-K · filed 2022-06-08 |
| 2020-12-31 | -$0.32 10-Q · filed 2022-02-04 | -$0.58 derived: net income ÷ weighted average shares · filed 2022-02-04 | -$0.94 10-Q · filed 2022-02-04 | |
| 2020-09-30 | -$0.25 10-Q · filed 2021-11-05 | -$0.61 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | -$0.38 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |